美股A股
StockGist
Back
10-Q2026-05-12· deepseek-chat

SNWV · SANUWAVE Health, Inc.

0001628280-26-034145

SEC filing

Summary

Mixed Q1: modest revenue growth and improved cash flow, but operating loss widened on higher SG&A and R&D spending.

Key takeaways

Full analysis

Revenue Growth Driven by Disposables Volume

Revenue for the three months ended March 31, 2026 was $9.6 million, an increase of 3.0% compared to $9.3 million in the same period in 2025. The growth was primarily driven by higher volume of UltraMIST disposables, partially offset by a decline in system sales. Gross profit increased to $7.4 million from $7.4 million, representing a gross margin of 77.3%. The decrease in gross margin was largely driven by a decrease in pricing on our UltraMIST systems and applicators due to a higher reseller mix.

Operating Loss on Higher Spending

Net Loss Improvement on Non-Recurring Items

Positive Operating Cash Flow

Balance Sheet and Liquidity